Liu Haibo, Wang Yanfeng, Huang Jiali, Dong Zhengqi, Xiao Peigen
Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100193, China.
Key Laboratory of Traditional Chinese Medicine Patent Information Resources, State Administration of Traditional Chinese Medicine, Beijing 100080, China.
Chin Herb Med. 2024 May 18;16(3):412-421. doi: 10.1016/j.chmed.2024.03.005. eCollection 2024 Jul.
The concept of substances of medicine food homology (SMFH) has garnered significant attention in recent years. This study conducts a systematic analysis of patent literature related to SMFH, and elucidates the development trends, technical hotspots, and the overall patent protection landscape of SMFH in China over the past two decades.
The patent search focused on the SMFH varieties as the objects of inquiry, with retrieval conducted in patent databases. Subsequently, the acquired data underwent processing, analysis, and visualization.
While the technical threshold for pharmaceutical applications surpasses that of the food service sector, the former may assume a prominent role in the future. Research and development (R&D) activities in the southeast of China demonstrate robust activity than other regions. Colleges and scientific research institutions exhibit substantial advantages in patent applications compared with individuals and hold greater potential for future development.
The findings of this patent analysis indicate that China's SMFH industry are presently undergoing a transition from an extensive model to a high-quality model. The quality and technical standards of SMFH products are consistently improving. Consequently, there is a need for more stringent patent application requirements to align with the evolving development needs.
药食同源物质的概念近年来备受关注。本研究对与药食同源物质相关的专利文献进行系统分析,阐明过去二十年中国药食同源物质的发展趋势、技术热点及整体专利保护态势。
以药食同源物质品种为检索对象,在专利数据库中进行检索。随后,对获取的数据进行处理、分析和可视化。
虽然医药应用的技术门槛高于食品服务领域,但前者未来可能发挥突出作用。中国东南部的研发活动比其他地区更为活跃。高校和科研机构在专利申请方面相比个人具有显著优势,且未来发展潜力更大。
该专利分析结果表明,中国药食同源产业目前正从粗放型模式向高质量模式转变。药食同源产品的质量和技术标准在不断提高。因此,需要更严格的专利申请要求以适应不断变化的发展需求。